Detalhe da pesquisa
1.
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.
N Engl J Med
; 388(23): 2145-2158, 2023 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36972026
2.
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
N Engl J Med
; 389(23): 2162-2174, 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38055253
3.
Plasma cell-free DNA methylation analysis for ovarian cancer detection: Analysis of samples from a case-control study and an ovarian cancer screening trial.
Int J Cancer
; 154(4): 679-691, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37861205
4.
International expert consensus on the surgical anatomic classification of radical hysterectomies.
Am J Obstet Gynecol
; 230(2): 235.e1-235.e8, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37788719
5.
ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design.
Int J Gynecol Cancer
; 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38627035
6.
Patient satisfaction with ultrasound, whole-body CT and whole-body diffusion-weighted MRI for pre-operative ovarian cancer staging: a multicenter prospective cross-sectional survey.
Int J Gynecol Cancer
; 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38531539
7.
Consensus on surgical technique for sentinel lymph node dissection in cervical cancer.
Int J Gynecol Cancer
; 34(4): 504-509, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38378695
8.
Direct mailing of HPV self-sampling kits to women aged 50-65 non-participating in cervical screening in the Czech Republic.
Eur J Public Health
; 34(2): 361-367, 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38224266
9.
The WID-qEC test: Performance in a hospital-based cohort and feasibility to detect endometrial and cervical cancers.
Int J Cancer
; 152(6): 1269-1274, 2023 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36056582
10.
The WID-EC test for the detection and risk prediction of endometrial cancer.
Int J Cancer
; 152(9): 1977-1988, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36533702
11.
Primary Mucinous Tumors of the Ovary: An Interobserver Reproducibility and Detailed Molecular Study Reveals Significant Overlap Between Diagnostic Categories.
Mod Pathol
; 36(1): 100040, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36788074
12.
Maintenance olaparib in patients with platinum-sensitive relapsed ovarian cancer: Outcomes by somatic and germline BRCA and other homologous recombination repair gene mutation status in the ORZORA trial.
Gynecol Oncol
; 172: 121-129, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37030280
13.
Stratification of lymph node metastases as macrometastases, micrometastases, or isolated tumor cells has no clinical implication in patients with cervical cancer: Subgroup analysis of the SCCAN project.
Gynecol Oncol
; 168: 151-156, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36442426
14.
Role of adjuvant therapy in intermediate-risk cervical cancer patients - Subanalyses of the SCCAN study.
Gynecol Oncol
; 170: 195-202, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36706646
15.
Analysis of risk factors for recurrence in cervical cancer patients after fertility-sparing treatment: The FERTIlity Sparing Surgery retrospective multicenter study.
Am J Obstet Gynecol
; 228(4): 443.e1-443.e10, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36427596
16.
Survival associated with extent of radical hysterectomy in early-stage cervical cancer: a subanalysis of the Surveillance in Cervical CANcer (SCCAN) collaborative study.
Am J Obstet Gynecol
; 229(4): 428.e1-428.e12, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37336255
17.
HPV testing as an effective triage strategy in the follow-up after fertility-sparing treatment for glandular lesions of the uterine cervix.
Int J Gynecol Cancer
; 2023 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38054269
18.
MILACC study: could undetected lymph node micrometastases have impacted recurrence rate in the LACC trial?
Int J Gynecol Cancer
; 33(11): 1684-1689, 2023 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37652529
19.
AGO-OVAR 28/ENGOT-ov57. Niraparib alone versus niraparib in combination with bevacizumab in patients with carboplatin-taxane-based chemotherapy in advanced ovarian cancer: a multicenter randomized phase III trial.
Int J Gynecol Cancer
; 33(12): 1966-1969, 2023 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37935524
20.
PARa-aOrtic LymphAdenectomy in locally advanced cervical cancer (PAROLA trial): a GINECO, ENGOT, and GCIG study.
Int J Gynecol Cancer
; 33(2): 293-298, 2023 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36717163